Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$519M |
| 2 |
Netflix
NFLX
|
+$448M |
| 3 |
Qualcomm
QCOM
|
+$280M |
| 4 |
Microsoft
MSFT
|
+$252M |
| 5 |
Broadcom
AVGO
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$453M |
| 2 |
ExxonMobil
XOM
|
+$234M |
| 3 |
GMS
GMS Inc
GMS
|
+$217M |
| 4 |
SKX
Skechers
SKX
|
+$201M |
| 5 |
Capital One
COF
|
+$193M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 17.99% |
| 3 | Industrials | 12.15% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Healthcare | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
US Global Investors
GROW
$36.3M
| $155K | ﹤0.01% |
56,506
-6,255
| -10% | -$15.5K |
|
|
ATYR
3152
aTyr Pharma
ATYR
$46.4M
| $155K | ﹤0.01% |
214,546
| – | – |
|
3153
Champions Oncology
CSBR
$85.1M
| $153K | ﹤0.01% |
23,702
+1,297
| +6% | +$9.14K |
|
3154
PepGen
PEPG
$133M
| $153K | ﹤0.01% |
33,006
-6,693
| -17% | -$10.8K |
|
3155
SOPHiA GENETICS
SOPH
$480M
| $148K | ﹤0.01% |
31,332
+6,205
| +25% | +$21.3K |
|
|
TOUR
3156
Tuniu
TOUR
$55.4M
| $147K | ﹤0.01% |
15,488
-1,665
| -10% | -$14.4K |
|
3157
AXT Inc
AXTI
$3.09B
| $145K | ﹤0.01% |
+32,260
| New | +$92.2K |
|
3158
Avalo Therapeutics
AVTX
$976M
| $143K | ﹤0.01% |
+11,215
| New | +$96.5K |
|
|
SRG
3159
Seritage Growth Properties
SRG
$130M
| $141K | ﹤0.01% |
33,347
+1,410
| +4% | +$4.93K |
|
3160
Intellicheck
IDN
$73.5M
| $137K | ﹤0.01% |
26,412
| – | – |
|
3161
Immuneering
IMRX
$279M
| $137K | ﹤0.01% |
19,562
+6,196
| +46% | +$32.2K |
|
|
ACB
3162
Aurora Cannabis
ACB
$165M
| $135K | ﹤0.01% |
22,649
-57,447
| -72% | -$280K |
|
3163
Baytex Energy
BTE
$3.08B
| $131K | ﹤0.01% |
55,792
| – | – |
|
|
TAIT
3164
DELISTED
Taitron Components
TAIT
| $131K | ﹤0.01% |
52,764
-12,707
| -19% | -$29.1K |
|
3165
NovaGold Resources
NG
$2.6B
| $128K | ﹤0.01% |
14,490
-17,810
| -55% | -$109K |
|
3166
Leslie's
LESL
$11.6M
| $126K | ﹤0.01% |
22,958
-4,373
| -16% | -$32.2K |
|
3167
Solid Power
SLDP
$468M
| $124K | ﹤0.01% |
35,794
-19,084
| -35% | -$71.9K |
|
3168
RAVE Restaurant Group
RAVE
$44.5M
| $120K | ﹤0.01% |
36,104
| – | – |
|
3169
Tenaya Therapeutics
TNYA
$168M
| $119K | ﹤0.01% |
73,408
| – | – |
|
3170
Koss Corp
KOSS
$35.5M
| $119K | ﹤0.01% |
23,342
+12,661
| +119% | +$71.7K |
|
3171
Ironwood Pharmaceuticals
IRWD
$611M
| $118K | ﹤0.01% |
90,373
| – | – |
|
3172
Willamette Valley Vineyards
WVVI
$13.5M
| $118K | ﹤0.01% |
32,441
| – | – |
|
3173
Mannatech
MTEX
$8.68M
| $116K | ﹤0.01% |
11,831
-17
| -0.1% | -$147 |
|
3174
Bioceres Crop Solutions
BIOX
$21.9M
| $115K | ﹤0.01% |
81,671
| – | – |
|
3175
Melco Resorts & Entertainment
MLCO
$2.1B
| $115K | ﹤0.01% |
12,553
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Dimensional Fund Advisors held 3,356 positions worth $466B, up 7.9% from $432B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q3 2025 filing shows 84 new, 1,582 increased, 1,511 reduced and 85 closed positions. Its largest new stake was Qiagen: 1,300,037 shares worth $58.1M. The largest sale was Hess, an estimated $453M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q3 2025 buy was Qiagen: 1,300,037 shares worth $58.1M.
- Dimensional Fund Advisors added most to Chevron in Q3 2025, an estimated $519M increase.
- Dimensional Fund Advisors's biggest Q3 2025 reduction was ExxonMobil, cutting an estimated $234M.
- Dimensional Fund Advisors fully exited Hess in Q3 2025, selling an estimated $453M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $466B portfolio in Q3 2025.
- Dimensional Fund Advisors opened 84 new positions and closed 85 in Q3 2025.
- Dimensional Fund Advisors's portfolio value rose 7.9% quarter-over-quarter to $466B.
Based on Dimensional Fund Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.